CLINICAL_TRIALS
research
· 2025-11-21
Clinical Trial Update: Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication(Frequency Adjusted Same-dose Therapy for H. Pylori) [Phase 4]
Summary
A Phase 4 clinical trial compares tegoprazan plus amoxicillin given twice daily versus a thrice-daily regimen for Helicobacter pylori eradication; the study is …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: First People's Hospital of Hangzhou | Conditions: HELICOBACTER PYLORI INFECTIONS | Phase 4 | Status: NOT_YET_RECRUITING